Chu, P., Nakamoto, N., Taniki, N., Ojiro, K., Amiya, T., Makita, Y., . . . Kanai, T. (2017). On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C. PLoS One.
Chicago Style CitationChu, Po-sung, et al. "On-treatment Decrease of NKG2D Correlates to Early Emergence of Clinically Evident Hepatocellular Carcinoma After Interferon-free Therapy for Chronic Hepatitis C." PLoS One 2017.
MLA CitationChu, Po-sung, et al. "On-treatment Decrease of NKG2D Correlates to Early Emergence of Clinically Evident Hepatocellular Carcinoma After Interferon-free Therapy for Chronic Hepatitis C." PLoS One 2017.
Warning: These citations may not always be 100% accurate.